Our drug discovery services include assay development, high throughput drug screening, and hit validation. Multiple liquid handling robots support screening with our available 170,000 small molecule diversity library. Our facility includes a SpectraMax I3 microplate reader and comprehensive protein engineering infrastructure to support state-of-the-art drug screening of protein-protein and protein-drug interactions.
- Target protein engineering, expression, and manufacturing
- Fluorescence-based assay development and transfer
- Small molecule drug screening with 170,000 diversity library on site
- Capacity to screen customer provided libraries, including pre-screen plate replication
- Custom hit validation (in vitro, culture, and in vivo assays)